Search Results for 'china'
Contract Service Directory Companies
View All Buyers Guide Companies »
-
Breaking News | Excipients | Facilities | Industry News
Crystec Launches New R&D Center in China
New site in Haimen, Jiangsu province has been established following an invitation to participate in the Yangtze Delta Advanced Drug Development platform.Tim Wright, Editor, Contract Pharma 04.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News | Parenterals
WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China
Immediately boosts commercial Drug Substance and Drug Product capacities for WuXi Biologics to address surging manufacturing demands.Tim Wright, Editor, Contract Pharma 03.17.21
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Vetter Establishes Office in China
Additional office in Asia Pacific region to promote development of new business in China.Kristin Brooks 03.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China
Companies join forces in cell therapy applications and commercial-scale manufacturing.Tim Wright, Editor, Contract Pharma 02.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioNTech, Shanghai Fosun Pharma to Supply COVID-19 Vax to China
Sign an agreement to provide 100 million doses of their BNT162 mRNA-based vaccine candidate in 2021.Contract Pharma Staff 12.18.20
-
Excipients
Bye-Bye China?
Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.Michele Jermini and Enrico Polastro 11.17.20
-
Bio News | Breaking News | Facilities | Industry News
Crown Biosciences Opens Facility in China
Full operational capacity is expected in early 2021.Contract Pharma Staff 11.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Samsung Biologics Expands in China
Partners with Chinese biotech GeneQuantum Healthcare on ADC development.Contract Pharma Staff 11.03.20
-
Importing Clinical Supplies into China
Water Cooler Chat
-
Breaking News | Clinical Trials | Industry News
Octapharma Supports New COVID-19 Trial
Aims to assess if Intravenous Immunoglobulin (IVIG) can halt coronavirus progression to respiratory failureContract Pharma Staff 04.16.20
-
Bio News | Breaking News | Industry News | Inspections
WuXi Biologics Passes EMA GMP Inspection
Suzhou site clears regulatory hurdle with not critical findingsContract Pharma Staff 04.15.20
-
Breaking News | Facilities | Industry News
PharmaBlock Opens New Facility in Zhejiang, China
New chemistry and engineering technology center highlights the application of micropacked bed technology in continuous manufacturingContract Pharma Staff 04.15.20
-
Biologics, Proteins, Vaccines | Drug Development | Information Technology
Speeding Vaccine Development with Advanced Analytics
Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development processDr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 04.15.20
-
Drug Development | R&D
COVID-19 and the Importance of Combating Antimicrobial Resistance
Dr. Frank of Working to Fight AMR discusses the global COVID-19 pandemic and the critical need to address the public health crisis of Antimicrobial ResistanceOnline Exclusives Kristin Brooks, Contract Pharma 04.13.20
-
Breaking News | Facilities | Industry News
ISPE Award Honors New Pfizer Facility
Engineered and designed by CRB, Andover Clinical Manufacturing Facility focuses on integration and flexibility to speed patient therapiesContract Pharma Staff 04.13.20
-
Bio News | Breaking News | Facilities | Industry News
Seneca Completes Stem Cell Manufacturing Facility
Will be used to manufacture the company's lead stem cell therapy for clinical trials within ChinaContract Pharma Staff 04.13.20
-
Breaking News | Clinical Trials | Industry News | Supply Chain
Marken Expands Clinical Trial Services
Critical need for patients to receive treatment at home spurs sponsor requestsContract Pharma Staff 04.13.20
-
Collaborations & Alliances | Drug Development
Regeneron, Zai Lab Enter Strategic REGN1979 Alliance
Regeneron will receive $30 million upfront and is eligible to receive up to $160 million in additional regulatory and sales milestones.Contract Pharma Staff 04.08.20
-
Bio News | Breaking News | Industry News | Laboratory Testing
BGI Unveils Inflatable Biosafety Lab for COVID-19 Testing
Huo-Yan Air Lab modular air dome structure can be transported by air as standard freightContract Pharma Staff 04.06.20
-
Clinical Trials
COVID-19: Keeping Clinical Trials Moving
How DTP and virtual services keep clinical trials moving during pandemic and beyondAriette van Strien, President, Marken 04.06.20
-
Breaking News | Promotions & Moves
CMAB Biopharma Appoints Head of Quality
Ye Shi will be responsible for the overall management of the quality system within CMAB.Contract Pharma Staff 04.06.20
-
Breaking News | Industry News
FDA COVID-19 Update
Efforts underway to facilitate access to convalescent plasma for COVID-19 patientsContract Pharma Staff 04.06.20
-
Breaking News | CRO News | Industry News
Frontage Laboratories Acquires Biotranix
Expands drug metabolism and pharmacokinetic servicesContract Pharma Staff 04.03.20
-
Breaking News | Industry News | Promotions & Moves
-
APIs
SOPs to Spur Growth in API Manufacturing
CMOs see outsourcing prospects improveS. Harachand, Contributing Editor 04.01.20
-
The Supply Chain House of Cards
The COVID-19 pandemic exposes pressures on extended global supply chainsEmil W. Ciurczak, DoraMaxx Consulting 04.01.20
-
COVID-19 & Fear of the Unkown
We should be just as concerned with curbing the spread of fear, as we are the coronavirusTim Wright, Editor, Contract Pharma 04.01.20
-
Coronavirus SARS-CoV-2: Architecture of a Pandemic
Deconstructing the epidemiology of a global panic.Ben Locwin, Contributing Editor 04.01.20
-
Breaking News | Collaborations & Alliances | Industry News
Citius, Novellus Ink COVID-19 Pact
Citius to license novel stem-cell therapy for acute respiratory distress syndrome (ARDS) associated with COVID-1904.01.20
-
Breaking News | Collaborations & Alliances | Drug Development
Innovent, Alector Enter Oncology Alliance
To develop and commercialize an anti-SIRP-alpha antibody (Alector's AL008) for the treatment of oncology indications in China.03.31.20
-
cGMP Manufacture | Drug Development | Logistics | Supply Chain
COVID-19: Business Update
Thermo Fisher Scientific provides perspective on the COVID-19 pandemic and how the company is working to help minimize disruptionsOnline Exclusives Kristin Brooks, Contract Pharma 03.30.20
-
Bio News | Breaking News | Industry News
BioDuro to Develop COVID-19 Nanobody Therapeutic
Specialized COVID-19 team and technology assembled to accelerate discovery of new biologic03.27.20
-
Supply Chain
Best Practices for Supply Chain Disruption
Top 3 “Best Practice” methods for planning your product label orders during supply chain disruptionRob Freeman, Director of Business Development and Marketing, Label Solutions Inc. 03.27.20
-
Bio News | Breaking News | cGMP Manufacture | Scale-up/Technology Transfer
Sartorius Supports Coronavirus Vax Candidate
BIOSTAT STR single-use bioreactor system used for the upstream preparation of the recombinant vaccine03.25.20
-
Breaking News | Excipients | Industry News
Wacker Receives Excipient Certification
Eddyville, IA site awarded EXCiPACT GMP certificate03.24.20
-
Breaking News | Facilities | Industry News
CMAB Biopharma Resumes Full-Scale Operation
Suzhou, China site up and running following the coronavirus outbreak03.24.20
-
Breaking News | CRO News | Facilities | Industry News
ChemPartner Expands China Ops
Introduces new state-of-the-art global operation center in Shanghai03.20.20
-
Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Bright Path Labs Accepted into FDA's Emerging Technology Program
Scalable continuous manufacturing technology paves way for rapid, low-cost domestic API production03.19.20
-
Breaking News | Clinical Trials | Drug Development | Industry News | Trials & Filings
Roche Trial to Assess Actemra/RoActemra in COVID-19 Pneumonia
First Phase III global study of Actemra/RoActemra in this setting to evaluate the safety and efficacy in collaboration with BARDA03.19.20
-
Breaking News | Collaborations & Alliances
Altasciences, Amador Bioscience Enter Strategic Collaboration
The partnership aims to expand world-class capabilities and resources to promote drug development in China and North America.03.18.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Pfizer, BioNTech to Co-Develop Potential COVID-19 Vaccine
Will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection03.18.20
-
Breaking News | Industry News
Weather to Play Major Role in Coronavirus Spread
Researchers predict potential spread and seasonality for COVID-19 based on climate where virus appears to thrive03.16.20
-
Sanofi, Regeneron in COVID-19 Pact
Begin global Kevzara (sarilumab) clinical trial program in patients with severe COVID-1903.16.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioNTech Reports Progress on COVID-19 Vaccine Program
Partnered with Fosun in China and Pfizer elsewhere; anticipates start of clinical testing for vaccine in late April 202003.16.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Drug Development
Newsmakers: Thermo Fisher Scientific
Leon Wyszkowski discusses the company’s recent investments, the challenges biopharma companies face, and future needs in the outsourcing spaceOnline Exclusives03.16.20
-
Breaking News | Drug Development | Industry News
Gilead's Remdesivir Shows Promise in COVID-19
Antiviral drug being evaluated in two Phase III trials in patients with severe and moderate manifestations03.13.20
-
Breaking News
Advaite Produces COVID-19 Rapid Response Diagnostic Kits
Diagnostic testing kit, ADVAITE RAPCOV, has ability to provide results in 15-30 minutes from a drop of fingertip blood and offers a solution for mass screeningAdvaite 03.13.20
-
Breaking News
University of California Develops Coronavirus Test
Labs at UC San Francisco, UCLA and UC San Diego are now offering the in-house COVID-19 tests.03.13.20
-
Bio News | Breaking News | Facilities | Industry News
Chime Biologics Supports COVID-19 Outbreak in Wuhan
China-based CDMO launches stand-alone operationsContract Pharma Staff 03.12.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
WuXi Biologics Completes Biologics Mfg. Facility in Ireland
Designed to adopt both large scale commercial manufacturing using disposable bioreactors and next-gen continuous bioprocessing manufacturing technology03.11.20
